top of page

Opportunistic Bone Mineral Density (BMD) Screening 

With FDA-Approved AI-Enabled AutoBMD™


No Extra Radiation, No Capital Equipment
 

Applicable to New and Existing CT Scans

Sign up for a free demonstration and see how AutoBMD™ can add value to your practice.

bifold inside pg 2.png
bifold inside pg 1.png
Matthew J. Budoff, M.D.-1_WEB_0.jpg
“I have been advocating for BMD measurements in coronary artery calcium (CAC) scans for years. In my practice every patient who is undergoing a CAC or a lung cancer screening CT scan is offered a BMD report. We have the obligation to inform patients if their CT scan shows signs of bone loss, but we can’t report it quantitatively. AutoBMD™ does it with a high accuracy.”

Dr. Mathew Budoff

Professor of Medicine at the David Geffen School of Medicine at UCLA and the Director of Cardiac CT Lab at the Lundquist Institute

0000072500010044713201.jpg
“Providing high-risk people a DEXA equivalent FDA-approved BMD report with no additional radiation is an obvious benefit.”

Dr. David Yankelevitz

Professor of Radiology at Mount Sinai Hospital, NY. Lung Cancer Biopsy ACR Guidelines Committee Member

Morteza-Naghavi.jpg
“HeartLung is focused on AI-enabled early detection of subclinical preventable diseases such as coronary artery disease, lung cancer, osteoporosis, and fatty liver disease using CT scans which are available worldwide. AutoBMD™ is the first low-hanging fruit that we aimed and received FDA approval for. AutoCAC™ AutoLung™ and more will follow.”

Dr. Morteza Naghavi

Physician Inventor and Founder of HeartLung Technologies
President of SHAPE (Society for Heart Attack Prevention and Eradication) 

bottom of page